LV10246A - Jauni aizvietotie salicilskabes atvasinajumi - Google Patents

Jauni aizvietotie salicilskabes atvasinajumi

Info

Publication number: LV10246A
Authority: LV; Latvia
Prior art keywords: compound; new substituted; substituted salicylic; salicylic derivatives; het
Prior art date: 1991-11-18

Application number

LV920202A

Other languages

English (en)

Other versions

LV10246B (en

Inventor

Hubert Agback

Leif Ahrgren

Thomas Berglindh

Martin Haraldsson

Lars-Inge Olsson

Goeran Smedegard

Original Assignee

Kabi Pharmacia Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-11-18

Filing date

1992-11-13

Publication date

1994-10-20

1992-11-13 Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab

1994-10-20 Publication of LV10246A publication Critical patent/LV10246A/lv

1995-04-20 Publication of LV10246B publication Critical patent/LV10246B/xx

Links

150000001875 compounds Chemical class 0.000 abstract 4
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
208000023275 Autoimmune disease Diseases 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
125000000623 heterocyclic group Chemical group 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
229910052757 nitrogen Inorganic materials 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/20—Nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/14—Nitrogen atoms
- C07D261/16—Benzene-sulfonamido isoxazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Immunology (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Transplantation (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pyridine Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Thiazole And Isothizaole Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

LVP-92-202A 1991-11-18 1992-11-13 Novel substituted salicylic acids LV10246B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE9103397A SE9103397D0 (sv)	1991-11-18	1991-11-18	Nya substituerade salicylsyror

Publications (2)

Publication Number	Publication Date
LV10246A true LV10246A (lv)	1994-10-20
LV10246B LV10246B (en)	1995-04-20

Family

ID=20384352

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LVP-92-202A LV10246B (en)	1991-11-18	1992-11-13	Novel substituted salicylic acids

Country Status (29)

Country	Link
US (3)	US5302718A (lv)
EP (1)	EP0613468B1 (lv)
JP (1)	JP3259915B2 (lv)
KR (1)	KR100253748B1 (lv)
AT (1)	ATE194597T1 (lv)
AU (1)	AU668528B2 (lv)
CA (1)	CA2123697C (lv)
DE (1)	DE69231252T2 (lv)
DK (1)	DK0613468T3 (lv)
EE (1)	EE03026B1 (lv)
ES (1)	ES2149780T3 (lv)
FI (1)	FI106857B (lv)
GR (1)	GR3034585T3 (lv)
HU (2)	HU221476B (lv)
IL (1)	IL103665A (lv)
LT (1)	LT3182B (lv)
LV (1)	LV10246B (lv)
MX (1)	MX9206647A (lv)
MY (1)	MY130169A (lv)
NO (1)	NO300805B1 (lv)
NZ (1)	NZ244998A (lv)
PT (1)	PT101068B (lv)
RU (1)	RU2124501C1 (lv)
SE (1)	SE9103397D0 (lv)
SK (1)	SK282080B6 (lv)
TW (1)	TW304944B (lv)
UA (1)	UA42869C2 (lv)
WO (1)	WO1993010094A1 (lv)
ZA (1)	ZA928864B (lv)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5514696A (en) *	1992-05-06	1996-05-07	Bristol-Myers Squibb Co.	Phenyl sulfonamide endothelin antagonists
GB9310095D0 (en) *	1993-05-17	1993-06-30	Zeneca Ltd	Therapeutic compounds
US5965732A (en) *	1993-08-30	1999-10-12	Bristol-Myers Squibb Co.	Sulfonamide endothelin antagonists
US5405842A (en) *	1994-01-28	1995-04-11	Silverman; Bernard A.	Treatment of steroid dependent asthmatics
GB9504854D0 (en) *	1994-03-31	1995-04-26	Zeneca Ltd	Nitrogen derivatives
US5612359A (en) *	1994-08-26	1997-03-18	Bristol-Myers Squibb Company	Substituted biphenyl isoxazole sulfonamides
US5846990A (en) *	1995-07-24	1998-12-08	Bristol-Myers Squibb Co.	Substituted biphenyl isoxazole sulfonamides
CA2204616C (en) *	1995-09-18	2002-12-17	Ranjan Mukherjee	Ppar gamma antagonists for treating obesity
JPH09124620A (ja) *	1995-10-11	1997-05-13	Bristol Myers Squibb Co	置換ビフェニルスルホンアミドエンドセリン拮抗剤
JP2001523218A (ja)	1996-02-20	2001-11-20	ブリストル―マイヤーズ・スクイブ・カンパニー	ビフェニルイソキサゾール・スルホンアミドの製造法
US5856507A (en) *	1997-01-21	1999-01-05	Bristol-Myers Squibb Co.	Methods for the preparation of biphenyl isoxazole sulfonamides
US5939446A (en) *	1996-04-09	1999-08-17	Bristol-Myers Squibb Co.	Heteroaryl substituted phenyl isoxazole sulfonamide endothelin antagonists
JP3814742B2 (ja) *	1996-10-18	2006-08-30	イハラケミカル工業株式会社	４−フルオロサリチル酸類
WO1998033781A1 (en) *	1997-01-30	1998-08-06	Bristol-Myers Squibb Company	Method for preventing or treating low renin hypertension by administering an endothelin antagonist
TW536540B (en) *	1997-01-30	2003-06-11	Bristol Myers Squibb Co	Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
GB9804648D0 (en)	1998-03-06	1998-04-29	Zeneca Ltd	Chemical compounds
GB9805520D0 (en)	1998-03-17	1998-05-13	Zeneca Ltd	Chemical compounds
GB9811427D0 (en)	1998-05-29	1998-07-22	Zeneca Ltd	Chemical compounds
WO1999063980A1 (en)	1998-06-12	1999-12-16	Ligand Pharmaceuticals Inc.	Treatment of anti-estrogen resistant breast cancer using rxr modulators
AU3718900A (en)	1999-03-19	2000-10-09	Bristol-Myers Squibb Company	Methods for the preparation of biphenyl isoxazole sulfonamides
CA2381581A1 (en)	1999-09-04	2001-03-15	Astrazeneca Ab	Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity
US6878712B1 (en)	1999-09-04	2005-04-12	Astrazeneca Ab	Amides as inhibitors for pyruvate dehydrogenase
US6552225B1 (en)	1999-09-04	2003-04-22	Astrazeneca Ab	Chemical compounds
CA2307278A1 (en) *	2000-04-28	2001-10-28	University Of British Columbia	Use of n-heterocyclic substituted salicylic acids for inhibition of cellular uptake of cystine
EP1278521B1 (en) *	2000-04-28	2005-11-30	The University of British Columbia	N-heterocyclic substituted salicylates for the treatment of cancer
US6639082B2 (en)	2000-10-17	2003-10-28	Bristol-Myers Squibb Company	Methods for the preparation of biphenyl isoxazole sulfonamides
KR100360342B1 (ko) *	2002-04-19	2002-11-13	박계정	밸런스 머신의 언밸런스 수정위치 및 수정량의 자동 보상방법
WO2005023771A1 (ja) *	2003-09-05	2005-03-17	Ono Pharmaceutical Co., Ltd.	ケモカインレセプターアンタゴニストおよびその医薬用途
EP1696915A1 (en) *	2003-12-19	2006-09-06	Pfizer, Inc.	Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity
EP1763353A1 (en) *	2004-06-29	2007-03-21	Warner-Lambert Company LLC	COMBINATION THERAPIES UTILIZING BENZAMIDE INHIBITORS OF THE P2X<sb>7</sb> RECEPTOR
GB2421947A (en) *	2005-01-07	2006-07-12	Univ Southampton	Sulphonamide compounds for use as inhibitors of NF-kB
CA2643963A1 (en) *	2006-02-21	2007-08-30	Amgen Inc.	Cinnoline derivatives as phosphodiesterase 10 inhibitors
JP5304785B2 (ja) *	2008-06-23	2013-10-02	アステラス製薬株式会社	スルホンアミド化合物又はその塩
AU2012220620A1 (en) *	2011-02-23	2013-10-03	Icahn School Of Medicine At Mount Sinai	Inhibitors of bromodomains as modulators of gene expression
HUE050317T2 (hu)	2015-05-20	2020-11-30	Amgen Inc	APJ receptor triazol agonistái
CA3010615C (en)	2016-01-14	2024-02-20	Beth Israel Deaconess Medical Center, Inc.	Mast-cell modulators and uses thereof
US9988369B2 (en)	2016-05-03	2018-06-05	Amgen Inc.	Heterocyclic triazole compounds as agonists of the APJ receptor
WO2018093576A1 (en)	2016-11-16	2018-05-24	Amgen Inc.	Alkyl substituted triazole compounds as agonists of the apj receptor
WO2018093579A1 (en)	2016-11-16	2018-05-24	Amgen Inc.	Triazole phenyl compounds as agonists of the apj receptor
US11046680B1 (en)	2016-11-16	2021-06-29	Amgen Inc.	Heteroaryl-substituted triazoles as APJ receptor agonists
US10736883B2 (en)	2016-11-16	2020-08-11	Amgen Inc.	Triazole furan compounds as agonists of the APJ receptor
WO2018093577A1 (en)	2016-11-16	2018-05-24	Amgen Inc.	Cycloalkyl substituted triazole compounds as agonists of the apj receptor
EP3541803B1 (en)	2016-11-16	2020-12-23	Amgen Inc.	Triazole pyridyl compounds as agonists of the apj receptor
MA50509A (fr)	2017-11-03	2021-06-02	Amgen Inc	Agonistes de triazole fusionnés du récepteur apj
US11807624B2 (en)	2018-05-01	2023-11-07	Amgen Inc.	Substituted pyrimidinones as agonists of the APJ receptor
CN111056978B (zh) *	2019-12-13	2021-01-19	西安交通大学	一种磺酰胺类化合物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2396145A (en) *	1940-12-14	1946-03-05	Pharmscia Ab	Heterocyclic sulphonamido azo compounds
BE791889A (fr) *	1971-11-26	1973-05-24	Pharmacia Ab	Nouveaux derives de la pyridine
AU567140B2 (en) *	1984-01-06	1987-11-12	Shionogi & Co., Ltd.	Sulphonamido-benzamide derivatives
US4663334A (en) *	1985-12-11	1987-05-05	Mcneilab, Inc.	Heteroaromatic acetylenes useful as antihypertensive agents
US4897397A (en) *	1988-12-16	1990-01-30	Schering Corporation	Aryl-alkynoic, alkenoic or alkanoic compounds and compositions useful as antiallergy and anti-inflammatory agents

1991
- 1991-11-18 SE SE9103397A patent/SE9103397D0/xx unknown
1992
- 1992-11-03 NZ NZ244998A patent/NZ244998A/en not_active IP Right Cessation
- 1992-11-04 WO PCT/SE1992/000758 patent/WO1993010094A1/en not_active Ceased
- 1992-11-04 ES ES92924067T patent/ES2149780T3/es not_active Expired - Lifetime
- 1992-11-04 UA UA94005499A patent/UA42869C2/uk unknown
- 1992-11-04 JP JP50919193A patent/JP3259915B2/ja not_active Expired - Fee Related
- 1992-11-04 SK SK547-94A patent/SK282080B6/sk unknown
- 1992-11-04 HU HU9401391A patent/HU221476B/hu not_active IP Right Cessation
- 1992-11-04 AU AU29589/92A patent/AU668528B2/en not_active Ceased
- 1992-11-04 CA CA002123697A patent/CA2123697C/en not_active Expired - Fee Related
- 1992-11-04 EP EP92924067A patent/EP0613468B1/en not_active Expired - Lifetime
- 1992-11-04 DK DK92924067T patent/DK0613468T3/da active
- 1992-11-04 DE DE69231252T patent/DE69231252T2/de not_active Expired - Fee Related
- 1992-11-04 RU RU94028109A patent/RU2124501C1/ru not_active IP Right Cessation
- 1992-11-04 KR KR1019940701664A patent/KR100253748B1/ko not_active Expired - Fee Related
- 1992-11-04 AT AT92924067T patent/ATE194597T1/de not_active IP Right Cessation
- 1992-11-06 IL IL10366592A patent/IL103665A/xx not_active IP Right Cessation
- 1992-11-09 US US07/973,753 patent/US5302718A/en not_active Expired - Lifetime
- 1992-11-13 LV LVP-92-202A patent/LV10246B/xx unknown
- 1992-11-17 ZA ZA928864A patent/ZA928864B/xx unknown
- 1992-11-17 MY MYPI92002100A patent/MY130169A/en unknown
- 1992-11-17 LT LTIP229A patent/LT3182B/lt not_active IP Right Cessation
- 1992-11-17 PT PT101068A patent/PT101068B/pt not_active IP Right Cessation
- 1992-11-18 MX MX9206647A patent/MX9206647A/es not_active IP Right Cessation
- 1992-11-27 TW TW081109532A patent/TW304944B/zh active
1993
- 1993-10-07 US US08/132,874 patent/US5403930A/en not_active Expired - Fee Related
1994
- 1994-05-13 NO NO941799A patent/NO300805B1/no unknown
- 1994-05-17 FI FI942289A patent/FI106857B/fi not_active IP Right Cessation
- 1994-11-02 EE EE9400111A patent/EE03026B1/xx not_active IP Right Cessation
- 1994-12-29 US US08/365,869 patent/US5556855A/en not_active Expired - Fee Related
1995
- 1995-06-28 HU HU95P/P00492P patent/HU211163A9/hu unknown
2000
- 2000-10-09 GR GR20000402274T patent/GR3034585T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE69231252D1 (de)	2000-08-17
ZA928864B (en)	1993-05-13
LV10246B (en)	1995-04-20
NO300805B1 (no)	1997-07-28
EP0613468B1 (en)	2000-07-12
ES2149780T3 (es)	2000-11-16
US5556855A (en)	1996-09-17
RU2124501C1 (ru)	1999-01-10
LT3182B (en)	1995-03-27
HU9401391D0 (en)	1994-08-29
PT101068B (pt)	1999-08-31
KR100253748B1 (ko)	2000-05-01
ATE194597T1 (de)	2000-07-15
JP3259915B2 (ja)	2002-02-25
US5302718A (en)	1994-04-12
SE9103397D0 (sv)	1991-11-18
WO1993010094A1 (en)	1993-05-27
DE69231252T2 (de)	2001-03-01
HU211163A9 (en)	1995-10-30
SK54794A3 (en)	1995-02-08
HUT69723A (en)	1995-09-28
DK0613468T3 (da)	2000-10-23
JPH07501330A (ja)	1995-02-09
CA2123697C (en)	2003-12-09
FI942289L (fi)	1994-05-17
AU2958992A (en)	1993-06-15
NZ244998A (en)	1995-09-26
EE03026B1 (et)	1997-08-15
NO941799L (lv)	1994-06-22
HU221476B (en)	2002-10-28
IL103665A0 (en)	1993-04-04
GR3034585T3 (en)	2001-01-31
TW304944B (lv)	1997-05-11
MX9206647A (es)	1993-05-01
PT101068A (pt)	1994-02-28
MY130169A (en)	2007-06-29
LTIP229A (en)	1994-09-25
IL103665A (en)	1997-08-14
FI942289A0 (fi)	1994-05-17
SK282080B6 (sk)	2001-10-08
EP0613468A1 (en)	1994-09-07
US5403930A (en)	1995-04-04
NO941799D0 (no)	1994-05-13
AU668528B2 (en)	1996-05-09
UA42869C2 (uk)	2001-11-15
FI106857B (fi)	2001-04-30
CA2123697A1 (en)	1993-05-27

Publication	Publication Date	Title
LV10246A (lv)	1994-10-20	Jauni aizvietotie salicilskabes atvasinajumi
RU94028109A (ru)	1996-01-10	Новые замещенные салициловые кислоты, способ их получения
DK0638071T3 (da)	1997-10-27	Heterocykliske carboxylsyrederivater, der bindes til retenoidreceptorer (RAR)
FI940414A0 (fi)	1994-01-27	Kinoliini- tai kinatsoliinijohdannaiset, niiden valmistus ja käyttö
DK0715623T3 (da)	1999-02-22	Blodpladeaggregationsinhibitorer
PT100332A (pt)	1993-07-30	Agentes para o tratamento de doencas cardiovasculares derivados de piridina e imidazole
DK0613687T3 (da)	1999-12-06	Anvendelse af pregnanderivat til behandling af tumorer
SE9102909D0 (sv)	1991-10-09	New use
IL97277A0 (en)	1992-05-25	Beta-phenylisoserine derivative,and its preparation and application
BR9407298A (pt)	1996-10-01	Diidropiranopiridinas vasoconstritoras substituidas
DE59703968D1 (de)	2001-08-09	Neue polycyclische phthalazinderivate und ihre verwendung
CO4960643A1 (es)	2000-09-25	Nuevos derivados de aminoacidos, procedimientos para su preparacion y composiciones farmaceuticas que contienen estos compuestos (ii)